Wahyuni Indawati is a medical staff and clinical lecturer in Respirology Division in Child Health Department in Faculty of Medicine University of Indonesia – Cipto Mangunkusumo National General Hospital. She earned her Medical Doctor, Pediatrician, and Pediatric consultant in Respirology from University of Indonesia. She is currently a PhD candidate from Universitair Medisch Centrum Utrecht – Julius Center for Health Sciences and Primary Care, Netherlands, with ongoing research focusing on early lung function of Indonesian infants (BRAVO Trial).
While pursuing her consultant of respirology, she was gaining for specific abilities in several trainings in numerous institutions. She participated in Cystic Fibrosis and Spirometry training in Erasmus University Sophia Children Hospital, Rotterdam, Bronchoscopy training in National University Hospital of Singapore and in University of Hongkong, also Tuberculosis training in Stellenbosch University, Cape Town, South Africa.
In order to gain research knowledge and skills, she was also participated in several short course of research training, including Clinical Epidemiology Workshop by AsiaLink Clinical Epidemiology & Evidence Based Medicine, Health System Operational Research Training by National Tuberculosis Operational Research Group (TORG), and Methods in Epidemiologic, Clinical and Operations Research (MECOR) by American Thoracic Society.
Mrs. Indawati is currently a recipient of Developing World Scholarship grant for her PhD degree from UMC Utrecht. She also received Desentralization Research Grant for University of Indonesia from Directorate General of Higher Education of Indonesia for her pilot study of Indonesian infant lung function.
In accordance to her professional work, she was a Secretary of Community Affair for Indonesian Pediatric Society. Currently she is a Secretary of Respirology Coordination Working Unit of Indonesian Pediatric Society and a Secretary of Pediatric Pharmacy Task Force of Indonesian Pediatric Society.
Wahyuni has been involved in an ongoing randomized trial in Jakarta, Indonesia called Breastfeeding Attitude and Volume Optimization (BRAVO) trial. BRAVO is a pragmatic parallel group randomized trial which aim to optimize breastfeeding practice through systematic empowerment of breastfeeding. In addition to that, it also studies the effect of breastfeeding on early signs of later chronic disease, particularly cardiovascular, respiratory and metabolic risks.
In this ongoing research, she is focusing her interests on the effect of breastfeeding to respiratory outcome, especially in early life.The respiratory outcome consists of infant lung function, respiratory tract microbiome and respiratory diseases such as infection and allergy.